Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under First Tracks Biotherapeutics, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Ajim Tamboli, Chief Financial Officer (Form 8-K filed 2026-04-20). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Sirenia Capital Management LP (filed 2026-08-14).
Who is behind it
First Tracks Biotherapeutics, Inc.: incorporated in Delaware; business address in San Diego, California; industry Pharmaceutical Preparations (Schedule 13G, 2026-08-14).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-08-14 | Sirenia Capital Management LP | 7.2% |
| Schedule 13G, 2026-08-14 | Chen Yu | 8.3% |
| Schedule 13G, 2026-08-13 | Affinity Asset Advisors, LLC | 5.8% |
| Schedule 13G, 2026-08-06 | Fmr LLC | 5.9% |
| Schedule 13G, 2026-07-28 | Blackrock, Inc. | 5.5% |
| Schedule 13G, 2026-04-22 | Ecor1 Capital, LLC | 9.1% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-04-20 | Ajim Tamboli | Chief Financial Officer | appointed |
Money raised
Latest IPO step: First Tracks Biotherapeutics, Inc. filed to go public (S-1, 2026-05-08).
IPO filings: S-1, 2026-05-08; ticker TRAX on Nasdaq.
Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2026-04-20).
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/first-tracks-biotherapeuticsLast updated 2026-10-18
Who owns First Tracks Biotherapeutics, Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/first-tracks-biotherapeutics